Rapid Therapeutic Science Laboratories, Inc. (RTSL)

USD 0.0

(0.0%)

Market Cap (In USD)

26.49 Thousand

Revenue (In USD)

-

Net Income (In USD)

-1.69 Million

Avg. Volume

10.95 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.001-0.006
PE
-
EPS
-
Beta Value
-11.468
ISIN
US7534312043
CUSIP
753431105
CIK
1575659
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Donal R. Schmidt Jr.
Employee Count
-
Website
https://www.rtslco.com
Ipo Date
2017-06-14
Details
Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company. The company engages in the aerosol delivery of non-psychoactive cannabinoids to the blood stream for treatment of chronic pain, post-traumatic stress disorder, insomnia, surgery recovery, and other ailments. It offers pressurized meter dose inhaler, a device that delivers a measured amount of aerosolized inhalant in a mist to the lungs; sublingual oral spray devices; and water-soluble cannabidiol and cannabigerol isolates under the nhaler brand. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas. Rapid Therapeutic Science Laboratories, Inc. was a former subsidiary of Texas Mdi, Inc.